查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968639

醫用同位素生產市場分析及預測（至2035年）：類型、產品類型、服務、技術、應用、最終用戶、製程、組件和模式

Medical Isotope Production Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Process, Component, Mode
出版日期: | 出版商: Global Insight Services | 英文 325 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計醫用同位素生產市場規模將從2024年的64億美元成長到2034年的210億美元，複合年成長率約為12.6%。醫用同位素生產市場涵蓋用於醫學診斷和治療的同位素的生產。這些同位素在核子醫學程序中至關重要，包括診斷影像和癌症治療。市場成長的驅動力來自醫療技術的進步、慢性病發病率的上升以及對精準診斷工具的需求。為了滿足不斷成長的需求並應對監管挑戰，確保同位素的可靠供應和生產方法的創新至關重要。在基礎設施和研發投資的推動下，該產業蓄勢待發，即將迎來成長。

医療用同位体生産市場は、診断,治療用途の需要増加を背景に堅調な成長を遂げております。診断分野では、Technetium99mがその優れた特性から核子醫學掃描術診斷で広く利用され、依然として主力同位体としての地位を維持しております。治療分野では、ヨウ素131が甲状腺疾患や特定のがん治療に広く用いられ、主要同位体としての地位を確立しております。続いて鎦177が治療分野、特に標靶放射性核治療において注目を集めており、将来性が期待されています。生産方法においては、確立されたインフラと大規模生産能力を背景に、核子反應爐ベースの生産が主流を占めています。技術進歩と短寿命同位体への需要増加を背景に、サイクロトロンベースの生産が重要なサブセグメントとして台頭しています。研究開発への投資は、同位体生産技術の革新と応用範囲の拡大において極めて重要です。医療機関と生産施設間の戦略的連携は、世界の需要を満たし、サプライチェーンの回復力を確保する上で極めて重要です。

市場區隔
類型 放射性同位素，穩定同位素
產品 Technetium-99m、碘-131、氙-133、鉈-201、鎵-67、銥-192、鍶-89、釔-90、碳-14
服務 同位素富集、客製化合成、放射性標記、物流配送、諮詢服務、品質保證、法規遵循
科技 迴旋加速器、核子反應爐、線性加速器、中子活化分析、核分裂、核融合、放射性同位素產生器
目的 診斷、治療、研究、工業、農業、環境研究、輻射安全
最終用戶 醫院、研究實驗室、製藥公司、學術機構、工業實驗室、核子醫學中心
過程 靶材照射、化學處理、純化、品管、包裝及配送
成分 靶材、輻照設備、加工設備、品管系統、包裝解決方案
製造形式 本地生產、外包生產、契約製造

市場概況：

醫用同位素生產市場參與企業眾多，各自構成了一個充滿活力的競爭格局。市場佔有率主要受策略定價和創新同位素的推出影響。近期產品推出進一步加劇了競爭，各公司力求透過提高療效和安全性來打造差異化產品。定價策略日趨複雜，反映了供應鏈物流和技術進步之間錯綜複雜的相互作用。北美仍然是主導的市場，而新興市場在醫療投資增加和技術應用的推動下正經歷強勁成長。醫用同位素生產市場的競爭日益激烈，主要參與者透過策略聯盟和收購爭奪主導。法規結構，尤其是在北美和歐洲，對生產和分銷設定了嚴格的標準，顯著影響市場動態。這些法規在確保品質和安全的同時，也對新進入者構成了障礙。市場前景廣闊，同位素應用技術和生產方法的創新將帶來巨大的成長潛力。然而，監管合規和生產成本等挑戰依然存在，需要策略遠見和投資。

主要趨勢和促進因素：

受核醫和放射性藥物技術進步的推動，醫用同位素生產市場正經歷強勁成長。一個關鍵趨勢是，由於慢性病發病率的上升，對診斷影像同位素（例如Technetium-99m）的需求不斷成長。生產技術的創新也促進了這項需求的成長，並提高了同位素的可用性和安全性。此外，向核子反應爐生產方法（例如迴旋加速器技術）的轉變，正在減少對核子反應爐的依賴，並最大限度地減少對環境的影響。監管支持和政府資助是該領域研發的關鍵促進因素。新興市場醫療基礎設施的擴展也進一步推動了需求。此外，對個人化醫療和標靶治療的日益重視，正在推動治療性同位素（例如鎦-177）的使用。投資於永續同位素生產和分銷網路的公司將能夠更好地掌握這些趨勢。隨著人們對核醫益處的認知不斷提高，該市場正處於持續成長和創新的黃金時期。

限制與挑戰：

醫用同位素生產市場面臨許多重大限制與挑戰。其中一個關鍵挑戰是複雜且區域差異顯著的監管環境，這導致核准延遲並增加合規成本。這種複雜性會抑制創新並減緩市場成長。供應鏈脆弱性也是一個重要的阻礙因素。對有限生產設施的依賴以及地緣政治緊張局勢可能會擾亂同位素生產所需原料的供應，導致短缺和成本上升。技術限制也構成挑戰。醫用同位素生產需要先進技術，這些技術成本高且難以維護，尤其對於新興市場參與者而言。此外，該領域也面臨熟練專業人員短缺的問題。同位素生產所需的專業知識並不普及，造成了人才瓶頸。最後，公眾對核能技術的認知和安全擔憂可能會阻礙市場擴張。對輻射的誤解和恐懼可能會降低對醫用同位素應用的需求和支持。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 放射性同位素
    • 穩定同位素
  • 市場規模及預測：依產品分類
    • Technetium-99m
    • 碘-131
    • 氙-133
    • 鉈-201
    • 鎵-67
    • 銥-192
    • 鍶-89
    • 釔90
    • 碳-14
  • 市場規模及預測：依服務分類
    • 同位素富集
    • 客製合成
    • 放射性標記
    • 物流與配送
    • 諮詢服務
    • 品質保證
    • 監理合規
  • 市場規模及預測：依技術分類
    • 迴旋加速器
    • 核子反應爐
    • 線性加速器
    • 中子活化分析
    • 核分裂
    • 核融合
    • 放射性同位素產生器
  • 市場規模及預測：依應用領域分類
    • 診斷
    • 治療藥物
    • 研究
    • 工業的
    • 農業
    • 環境研究
    • 輻射安全措施
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 研究所
    • 製藥公司
    • 學術機構
    • 工業研究院
    • 核子醫學中心
  • 市場規模及預測：依製程分類
    • 標靶照射
    • 化學處理
    • 純化
    • 品管
    • 包裝
    • 分配
  • 市場規模及預測：依組件分類
    • 目標物質
    • 照射裝置
    • 加工設備
    • 品管系統
    • 包裝解決方案
  • 市場規模及預測：依方法
    • 本地生產
    • 異地生產
    • 契約製造

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • SHINE Medical Technologies
  • NorthStar Medical Radioisotopes
  • Advanced Accelerator Applications
  • BWX Technologies
  • Eckert & Ziegler Strahlen-und Medizintechnik
  • ITM Isotopen Technologien Munchen
  • NTP Radioisotopes
  • Curium Pharma
  • Canadian Nuclear Laboratories
  • SCK CEN Belgian Nuclear Research Centre
  • Iotron Industries
  • ANSTO Health
  • Nordion
  • TerraPower
  • Cyclomedical Applications Group

第9章：關於我們

簡介目錄
Product Code: GIS34032

Medical Isotope Production Market is anticipated to expand from $6.4 billion in 2024 to $21 billion by 2034, growing at a CAGR of approximately 12.6%. The Medical Isotope Production Market encompasses the generation of isotopes for diagnostic and therapeutic applications in medicine. These isotopes are crucial for nuclear medicine procedures, including imaging and cancer treatment. The market is driven by advancements in healthcare technologies, increasing prevalence of chronic diseases, and the need for precise diagnostic tools. Efforts to secure reliable isotope supply and innovation in production methods are pivotal, as they address both rising demand and regulatory challenges. This sector is poised for growth, propelled by investments in infrastructure and research.

The Medical Isotope Production Market is experiencing robust growth, spurred by rising demand for diagnostic and therapeutic applications. In the diagnostic segment, Technetium-99m remains the top-performing isotope, widely utilized in nuclear medicine imaging due to its favorable properties. The therapeutic segment sees Iodine-131 as a leading isotope, extensively employed in the treatment of thyroid disorders and certain cancers. Following closely, Lutetium-177 is gaining traction in the therapeutic space, particularly for targeted radionuclide therapy, indicating a promising future. Among production methods, reactor-based production dominates due to its established infrastructure and capacity for large-scale output. Cyclotron-based production is emerging as a significant sub-segment, driven by advancements in technology and the growing need for short-lived isotopes. Investment in research and development is crucial, fostering innovation in isotope production technologies and expanding applications. Strategic collaborations between healthcare institutions and production facilities are pivotal in meeting global demand and ensuring supply chain resilience.

Market Segmentation
TypeRadioisotopes, Stable Isotopes
ProductTechnetium-99m, Iodine-131, Xenon-133, Thallium-201, Gallium-67, Iridium-192, Strontium-89, Yttrium-90, Carbon-14
ServicesIsotope Enrichment, Custom Synthesis, Radiolabeling, Logistics and Distribution, Consultation Services, Quality Assurance, Regulatory Compliance
TechnologyCyclotron, Nuclear Reactor, Linear Accelerator, Neutron Activation, Fission, Fusion, Radioisotope Generator
ApplicationDiagnostics, Therapeutics, Research, Industrial, Agricultural, Environmental Studies, Radiation Safety
End UserHospitals, Research Institutes, Pharmaceutical Companies, Academic Institutions, Industrial Laboratories, Nuclear Medicine Centers
ProcessTarget Irradiation, Chemical Processing, Purification, Quality Control, Packaging, Distribution
ComponentTarget Material, Irradiation Device, Processing Equipment, Quality Control Systems, Packaging Solutions
ModeOn-Site Production, Off-Site Production, Contract Manufacturing

Market Snapshot:

The Medical Isotope Production Market is characterized by a diverse array of market participants, each contributing to a dynamic competitive landscape. Market share is primarily influenced by strategic pricing and the introduction of innovative isotopes. Recent product launches have further intensified competition, as companies seek to differentiate their offerings by enhancing efficacy and safety. Pricing strategies are increasingly sophisticated, reflecting the complex interplay of supply chain logistics and technological advancements. North America remains a dominant force, yet emerging markets are witnessing robust growth, driven by increased healthcare investments and technological adoption. Competition within the Medical Isotope Production Market is intensifying, with key players vying for leadership through strategic alliances and acquisitions. Regulatory frameworks, particularly in North America and Europe, significantly impact market dynamics, setting stringent standards for production and distribution. These regulations ensure quality and safety but also pose barriers to entry for new players. The market's future is promising, with innovations in isotope applications and production methods offering significant growth potential. However, challenges such as regulatory compliance and production costs persist, necessitating strategic foresight and investment.

Geographical Overview:

The medical isotope production market is witnessing notable growth across various regions, each presenting unique opportunities. North America is at the forefront, driven by advanced healthcare infrastructure and increased demand for diagnostic imaging. The presence of leading pharmaceutical companies further propels the market. Europe follows, with significant investments in nuclear medicine and a strong emphasis on research and development. The region's commitment to healthcare innovation enhances its market potential. In Asia Pacific, rapid economic growth and expanding healthcare services are key drivers. Countries like China and India are emerging as pivotal players, investing heavily in medical isotope production capabilities. Latin America and the Middle East & Africa are nascent yet promising markets. In Latin America, growing healthcare awareness and infrastructure development fuel demand. Meanwhile, the Middle East & Africa are recognizing the importance of medical isotopes in advancing healthcare outcomes. These regions are poised for growth as they enhance their healthcare systems and invest in isotope production technologies.

Key Trends and Drivers:

The medical isotope production market is experiencing robust growth, driven by advancements in nuclear medicine and radiopharmaceuticals. A key trend is the increasing demand for diagnostic imaging isotopes, such as Technetium-99m, due to rising chronic disease prevalence. This surge is complemented by innovations in production technologies, enhancing isotope availability and safety. Moreover, the shift towards non-reactor-based production methods, like cyclotron technology, is gaining traction, reducing reliance on nuclear reactors and minimizing environmental impact. Regulatory support and government funding are pivotal drivers, as they facilitate research and development in this sector. The expansion of healthcare infrastructure in emerging markets further propels demand. Additionally, the growing emphasis on personalized medicine and targeted therapies is fostering the use of therapeutic isotopes, such as Lutetium-177. Companies investing in sustainable isotope production and distribution networks are well-positioned to capitalize on these trends. As awareness of nuclear medicine's benefits increases, the market is poised for sustained growth and innovation.

Restraints and Challenges:

The medical isotope production market encounters several significant restraints and challenges. A primary challenge is the regulatory landscape, which is complex and varies across regions, leading to delays in approvals and increased compliance costs. This complexity can hinder innovation and slow market growth. Supply chain vulnerabilities represent another critical restraint. The reliance on a limited number of production facilities and geopolitical tensions can disrupt the supply of raw materials necessary for isotope production, leading to shortages and increased costs. Technological limitations also pose a challenge. The production of medical isotopes requires sophisticated technology, which can be costly and difficult to maintain, especially for emerging market players. Additionally, there is a shortage of skilled professionals in the field. The specialized knowledge required for isotope production is not widely available, creating a bottleneck in workforce availability. Lastly, public perception and safety concerns about nuclear technology can impede market expansion. Misunderstandings and fears about radiation can reduce demand and support for medical isotope applications.

Key Players:

SHINE Medical Technologies, NorthStar Medical Radioisotopes, Advanced Accelerator Applications, BWX Technologies, Eckert & Ziegler Strahlen- und Medizintechnik, ITM Isotopen Technologien M\unchen, NTP Radioisotopes, Curium Pharma, Canadian Nuclear Laboratories, SCK CEN Belgian Nuclear Research Centre, Iotron Industries, ANSTO Health, Nordion, TerraPower, Cyclomedical Applications Group

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Component
  • 2.9 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Radioisotopes
    • 4.1.2 Stable Isotopes
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Technetium-99m
    • 4.2.2 Iodine-131
    • 4.2.3 Xenon-133
    • 4.2.4 Thallium-201
    • 4.2.5 Gallium-67
    • 4.2.6 Iridium-192
    • 4.2.7 Strontium-89
    • 4.2.8 Yttrium-90
    • 4.2.9 Carbon-14
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Isotope Enrichment
    • 4.3.2 Custom Synthesis
    • 4.3.3 Radiolabeling
    • 4.3.4 Logistics and Distribution
    • 4.3.5 Consultation Services
    • 4.3.6 Quality Assurance
    • 4.3.7 Regulatory Compliance
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Cyclotron
    • 4.4.2 Nuclear Reactor
    • 4.4.3 Linear Accelerator
    • 4.4.4 Neutron Activation
    • 4.4.5 Fission
    • 4.4.6 Fusion
    • 4.4.7 Radioisotope Generator
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Diagnostics
    • 4.5.2 Therapeutics
    • 4.5.3 Research
    • 4.5.4 Industrial
    • 4.5.5 Agricultural
    • 4.5.6 Environmental Studies
    • 4.5.7 Radiation Safety
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Research Institutes
    • 4.6.3 Pharmaceutical Companies
    • 4.6.4 Academic Institutions
    • 4.6.5 Industrial Laboratories
    • 4.6.6 Nuclear Medicine Centers
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Target Irradiation
    • 4.7.2 Chemical Processing
    • 4.7.3 Purification
    • 4.7.4 Quality Control
    • 4.7.5 Packaging
    • 4.7.6 Distribution
  • 4.8 Market Size & Forecast by Component (2020-2035)
    • 4.8.1 Target Material
    • 4.8.2 Irradiation Device
    • 4.8.3 Processing Equipment
    • 4.8.4 Quality Control Systems
    • 4.8.5 Packaging Solutions
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 On-Site Production
    • 4.9.2 Off-Site Production
    • 4.9.3 Contract Manufacturing

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Component
      • 5.2.1.9 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Component
      • 5.2.2.9 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Component
      • 5.2.3.9 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Component
      • 5.3.1.9 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Component
      • 5.3.2.9 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Component
      • 5.3.3.9 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Component
      • 5.4.1.9 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Component
      • 5.4.2.9 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Component
      • 5.4.3.9 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Component
      • 5.4.4.9 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Component
      • 5.4.5.9 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Component
      • 5.4.6.9 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Component
      • 5.4.7.9 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Component
      • 5.5.1.9 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Component
      • 5.5.2.9 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Component
      • 5.5.3.9 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Component
      • 5.5.4.9 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Component
      • 5.5.5.9 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Component
      • 5.5.6.9 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Component
      • 5.6.1.9 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Component
      • 5.6.2.9 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Component
      • 5.6.3.9 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Component
      • 5.6.4.9 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Component
      • 5.6.5.9 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 SHINE Medical Technologies
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 NorthStar Medical Radioisotopes
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Advanced Accelerator Applications
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 BWX Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Eckert & Ziegler Strahlen- und Medizintechnik
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 ITM Isotopen Technologien Munchen
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 NTP Radioisotopes
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Curium Pharma
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Canadian Nuclear Laboratories
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 SCK CEN Belgian Nuclear Research Centre
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Iotron Industries
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 ANSTO Health
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Nordion
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 TerraPower
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Cyclomedical Applications Group
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us